No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Avecho Biotechnology Receives $3 Million Licensing Fee From Sandoz for Cannabidiol Product; Shares Jump 20%
Avecho Biotechnology's 2024 Loss Narrows as Revenue Rises; Shares Fall 14%
Avecho Biotechnology Ltd: Annual Report 31 December 2024
Avecho Signs Licensing Agreement With Swiss Off-Patient Medicine Provider
Avecho Biotechnology Ltd: Appendix 4E - Preliminary Final Report
ASX Biggest Gainers